OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Expanding horizons in overcoming therapeutic resistance in castration-resistant prostate cancer: targeting the androgen receptor-regulated tumor immune microenvironment
Bisheng Cheng, Hai Huang
Cancer Biology and Medicine (2023), pp. 1-7
Open Access | Times Cited: 10
Bisheng Cheng, Hai Huang
Cancer Biology and Medicine (2023), pp. 1-7
Open Access | Times Cited: 10
Showing 10 citing articles:
Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway
Bisheng Cheng, Lingfeng Li, Tianlong Luo, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Bisheng Cheng, Lingfeng Li, Tianlong Luo, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Enhancing Radiation Therapy Response in Prostate Cancer Through Metabolic Modulation by Mito-Lonidamine: A 1H and 31P Magnetic Resonance Spectroscopy Study
Stepan Orlovskiy, Pradeep Kumar Gupta, Fernando Arias‐Mendoza, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 509-509
Open Access
Stepan Orlovskiy, Pradeep Kumar Gupta, Fernando Arias‐Mendoza, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 509-509
Open Access
Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
Xiang Wang, Wen Shen, Lan Yao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Xiang Wang, Wen Shen, Lan Yao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Sex and outcomes of patients with microsatellite instability-high andBRAFV600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors
Vincenzo Nasca, Joseph J. Zhao, Javier Ros, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010598-e010598
Open Access
Vincenzo Nasca, Joseph J. Zhao, Javier Ros, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010598-e010598
Open Access
Association of 5α-reductase inhibitor prescription with immunotherapy efficacy in metastatic renal cell carcinoma: a multicenter retrospective analysis
Bisheng Cheng, Jilin Wu, Ke Chen, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e011154-e011154
Open Access
Bisheng Cheng, Jilin Wu, Ke Chen, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e011154-e011154
Open Access
Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast Cancer
Priya Jayachandran, Sachin Kumar Deshmukh, Sharon Wu, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
Priya Jayachandran, Sachin Kumar Deshmukh, Sharon Wu, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
Bisheng Cheng, Yiming Lai, Hao Huang, et al.
Environmental Toxicology (2023) Vol. 39, Iss. 2, pp. 927-941
Closed Access | Times Cited: 10
Myeloid-Derived Suppressor Cells and Macrophage Polarization in Cancer Immunotherapy
Mohammad‐Salar Hosseini, Mohammad Amin Akbarzadeh, Farhad Jadidi‐Niaragh
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 157-204
Closed Access | Times Cited: 2
Mohammad‐Salar Hosseini, Mohammad Amin Akbarzadeh, Farhad Jadidi‐Niaragh
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 157-204
Closed Access | Times Cited: 2
Synergistic Strategies for Castration-Resistant Prostate Cancer: Targeting AR-V7, Exploring Natural Compounds, and Optimizing FDA-Approved Therapies
M M Rahman, Khadija Akter, Kazi Rejvee Ahmed, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2777-2777
Open Access
M M Rahman, Khadija Akter, Kazi Rejvee Ahmed, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2777-2777
Open Access
Bicalutamide Reveals Immunomodulatory Effects in Prostate Cancer by Regulating Immunogenic Dendritic Cell Maturation
Niloufar Sadat Nourbakhsh, Sirous Naeimi, Mehdi Moghanibashi, et al.
Tissue and Cell (2024) Vol. 91, pp. 102530-102530
Closed Access
Niloufar Sadat Nourbakhsh, Sirous Naeimi, Mehdi Moghanibashi, et al.
Tissue and Cell (2024) Vol. 91, pp. 102530-102530
Closed Access
Inhibiting HnRNP L-mediated alternative splicing of EIF4G1 counteracts immune checkpoint blockade resistance in Castration-resistant prostate Cancer
Xumin Zhou, Shilong Cheng, Zhongjie Chen, et al.
Neoplasia (2024) Vol. 60, pp. 101109-101109
Closed Access
Xumin Zhou, Shilong Cheng, Zhongjie Chen, et al.
Neoplasia (2024) Vol. 60, pp. 101109-101109
Closed Access
